STXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Stereotaxis, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$1.01+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $101.03M
- P/E (TTM)
- –
- Dividend yield
- –
Stereotaxis statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Electromedical & Electrotherapeutic Apparatus companies for comparison
Valuation
| Measure | Stereotaxis | Industry median |
|---|---|---|
| Market Cap | $101.20M | $230.55M |
| Enterprise Value | $90.71M | $202.97M |
| PS Ratio | 3.37 | 3.11 |
| PB Ratio | 8.27 | 3.14 |
| P/TBV Ratio | 40.13 | 4.57 |
Enterprise value
| Measure | Stereotaxis | Industry median |
|---|---|---|
| EV / Sales | 3.02 | 2.92 |
Income (trailing twelve months)
| Measure | Stereotaxis | Industry median |
|---|---|---|
| Revenue | $30.07M | $102.39M |
| Gross Profit | $16.71M | $60.36M |
| Operating Income | -$22.76M | -$4.31M |
| Net Income | -$22.32M | -$6.57M |
| EBITDA | -$22.76M | -$1.98M |
| EPS (Diluted) | -$0.24 | -$0.07 |
Margins
| Measure | Stereotaxis | Industry median |
|---|---|---|
| Gross Margin | 55.6% | 55.1% |
| Operating Margin | -75.7% | -6.04% |
| Profit Margin | -74.2% | -10.5% |
| EBITDA Margin | -75.7% | -2.67% |
| FCF Margin | -51.6% | -0.30% |
Returns
| Measure | Stereotaxis | Industry median |
|---|---|---|
| Return on Equity (ROE) | -325.9% | -19.2% |
| Return on Assets (ROA) | -46.1% | -13.3% |
| Return on Capital Employed (ROCE) | -79.1% | -9.07% |
Growth
| Measure | Stereotaxis | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -5.47% | 8.85% |
| Revenue Growth (3Y CAGR) | 4.78% | 7.08% |
| Revenue Growth (5Y CAGR) | 3.99% | 11.8% |
Balance sheet
| Measure | Stereotaxis | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $10.49M | $37.33M |
| Net Cash (Debt) | $10.49M | $3.92M |
| Net Cash Per Share | $0.10 | $0.28 |
| Equity (Book Value) | $12.24M | $57.36M |
| Book Value Per Share | $0.12 | $2.81 |
| Tangible Book Value | $2.52M | $10.71M |
| Working Capital | $11.19M | $54.64M |
Financial position
| Measure | Stereotaxis | Industry median |
|---|---|---|
| Current Ratio | 1.42 | 2.50 |
| Quick Ratio | 0.67 | 1.54 |
Cash flow (trailing twelve months)
| Measure | Stereotaxis | Industry median |
|---|---|---|
| Operating Cash Flow | -$15.29M | -$653.46K |
| Capital Expenditures | -$213.00K | -$3.69M |
| Free Cash Flow | -$15.50M | -$835.02K |
| FCF Per Share | -$0.15 | -$0.02 |
Efficiency
| Measure | Stereotaxis | Industry median |
|---|---|---|
| Asset Turnover | 0.62 | 0.59 |
| Inventory Turnover | 1.21 | 2.21 |
| Revenue Per Employee | $229.52K | $322.57K |
| Profits Per Employee | -$170.41K | -$51.88K |
| Employee Count | 131 | 185 |
Dividends and yields
| Measure | Stereotaxis | Industry median |
|---|---|---|
| Earnings Yield | -22.1% | -6.91% |
| FCF Yield | -15.3% | -0.56% |
| Buyback Yield | -21.0% | 0.78% |
| Shareholder Yield | -21.0% | 0.80% |
Shares
| Measure | Stereotaxis | Industry median |
|---|---|---|
| Shares Outstanding | 100,202,000 | 44,856,700 |
| Shares Change (YoY) | 11.1% | 3.35% |
| Float | 79,870,500 | 37,097,900 |
| Shares Held by Insiders | 20.3% | 10.6% |
| Shares Held by Institutions | 43.0% | 63.5% |
Scores
| Measure | Stereotaxis | Industry median |
|---|---|---|
| Altman Z-Score | -13.93 | 1.95 |
| Piotroski F-Score | 5 | 5 |
Calculated by StockData from Stereotaxis's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.